NCT07633522Not yet recruiting
Fire Needling Plus Filiform Needling for Chronic Migraine With Comorbid Tension-Type Headache
Clinical Research on Fire Needling Combined With Filiform Needling for Chronic Migraine With Comorbid Tension-type Headache
Source: ClinicalTrials.gov · Last updated 8 Jun 2026
Brief summary (registry, in English)
The investigators conducted a multicenter, prospective, randomized controlled clinical study to learn whether fire needling combined with filiform needling applied to pericranial muscle tenderness areas can effectively treat chronic migraine with comorbid tension-type headache. The study will also evaluate the safety and long-term efficacy of this therapy. Its main target questions include: 1. Can fire needling significantly reduce the number of headache days per month? 2. What is the effect of this therapy on headache intensity, emotional symptoms, and quality of life? The investigators will compare "fire needling at pericranial tender points plus conventional filiform needling" versus "conventional filiform needling alone" to verify whether the key technique of fire needling plus conventional filiform needling provides unique additive value. Participants will: 1. Receive treatment twice per week for 8 weeks (either in the experimental group or the control group)，attend a follow-up visit at week 24 after enrollment 2. Keep a headache diary (recording headache frequency, pain intensity, duration, associated symptoms, etc.) 3. Regularly complete assessments of emotional status, quality of life, and number of pericranial tender points
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 88 (estimated)
- First submitted
- 18 May 2026
- Start date
- Aug 2026
- Primary completion date
- Dec 2028
- Lead sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Diseases
- Migraine
- NCT number
- NCT07633522
What you commit to
- Study type: Interventional
- Planned participants: 88
- From Aug 2026 to the primary completion date, Dec 2028
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with alcohol or drug dependence;
- Patients who have received acupuncture treatment within 3 months prior to enrollment.
Other illness
- Patients with secondary headaches caused by intracranial space-occupying lesions, cranial infections, etc.;
- Patients complicated with severe heart, liver or kidney impairment, coagulation disorders, infections, severe immunocompromise, or allergic predisposition;
Other
- Patients complicated with cluster headache or other primary headaches;
- Patients who are unable to cooperate with acupuncture treatment;
- Women who are planning pregnancy, pregnant or breastfeeding;
Who the study is looking for
- Meets the diagnostic criteria for tension-type headaches with pericranial tenderness;
- Meets the diagnostic criteria for chronic migraine;
- 18 years ≤ age ≤ 65 years;
- Has sufficient understanding to complete the necessary examinations and tests for the study;
- Voluntarily joins this study and signs the informed consent form.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Capital Medical University Affiliated Beijing Tongren Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
| Beijing Tiantan Hospital,Capital Medical University Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
| Beijing Hospital of Traditional Chinese Medicine Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.